Cargando…
Current and Future Treatments for Classic Galactosemia
Type I (classic) galactosemia, galactose 1-phosphate uridylyltransferase (GALT)-deficiency is a hereditary disorder of galactose metabolism. The current therapeutic standard of care, a galactose-restricted diet, is effective in treating neonatal complications but is inadequate in preventing burdenso...
Autores principales: | Delnoy, Britt, Coelho, Ana I., Rubio-Gozalbo, Maria Estela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911353/ https://www.ncbi.nlm.nih.gov/pubmed/33525536 http://dx.doi.org/10.3390/jpm11020075 |
Ejemplares similares
-
Sweet and sour: an update on classic galactosemia
por: Coelho, Ana I., et al.
Publicado: (2017) -
Impaired fertility and motor function in a zebrafish model for classic galactosemia
por: Vanoevelen, Jo M., et al.
Publicado: (2017) -
The hypergonadotropic hypogonadism conundrum of classic galactosemia
por: Derks, Britt, et al.
Publicado: (2022) -
Novel mRNA therapy restores GALT protein and enzyme activity in a zebrafish model of classic galactosemia
por: Delnoy, Britt, et al.
Publicado: (2022) -
Fertility preservation in female classic galactosemia patients
por: van Erven, Britt, et al.
Publicado: (2013)